-
D. Boral Capital Reiterates "Buy" Rating for ImmunityBio (NASDAQ:IBRX)
Source: Buzz FX / 20 Dec 2024 10:56:14 America/New_York
D. Boral Capital Reiterates "Buy" Rating for ImmunityBio (NASDAQ:IBRX) Written by MarketBeat December 20, 2024 Share Link copied to clipboard. ImmunityBio ( NASDAQ:IBRX - Get Free Report ) 's stock had its "buy" rating restated by equities
Read more...